Condition: Conjunctival Diseases · Dry Eye Syndromes · Sponsor: Fondation Ophtalmologique Adolphe de Rothschild
Modifications of cell surface markers (including EMMPRIN) were observed in conjunctival epithelial cells during dry eye syndrome ; this study aims to describe the modifications of the repartition of these cell surface markers before and after initiation of a treatment.
This description comes directly from the study's public registry record.
Amélie YAVCHITZ · 01.48.03.64.33 · ayavchitz@for.paris
Always discuss trial participation with your own doctor first.
| Fondation Ophtalmologique A de Rothschild | Paris, France | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT03358979